EGFR-specific T cell frequencies correlate with EGFR expression in head and neck squamous cell carcinoma (Q35416013)

8 August 2017

EGFR-specific T cell frequencies correlate with EGFR expression in head and neck squamous cell carcinoma (English)

1 reference

8 August 2017

Sven Brandau

11

0 references

Robert L Ferris

object named as

Robert L Ferris

Claudia Alexandra Dumitru

9

0 references

7

object named as

Claudia A Dumitru

1 reference

8 August 2017

Patrick J Schuler

1

1 reference

8 August 2017

Petra Boeckers

2

1 reference

8 August 2017

Rainer Engers

3

1 reference

8 August 2017

Edwin Boelke

4

1 reference

8 August 2017

Murat Bas

5

1 reference

8 August 2017

Jens Greve

6

1 reference

8 August 2017

Goetz F Lehnerdt

8

1 reference

8 August 2017

Pedro A Andrade Filho

10

1 reference

8 August 2017

Stephan Lang

12

1 reference

8 August 2017

Theresa L Whiteside

13

1 reference

8 August 2017

Thomas K Hoffmann

14

1 reference

8 August 2017

language of work or name

1 reference

4 October 2011

1 reference

Journal of Translational Medicine

8 August 2017

1 reference

8 August 2017

9

1 reference

8 August 2017

168

1 reference

Creative Commons Attribution 2.0 Generic

8 August 2017

start time

4 October 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1479-5876-9-168

0 references

cites work

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Tricks tumors use to escape from immune control

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Platinum-based chemotherapy plus cetuximab in head and neck cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Gefitinib (ZD1839, Iressa) as palliative treatment in recurrent or metastatic head and neck cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Signaling through the epidermal growth factor receptor during the development of malignancy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

High steady-state levels of p53 are not a prerequisite for tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Establishment and characterization of cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs

27 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1479-5876-9-168

Novel immunogenic HLA-A*0201-restricted epidermal growth factor receptor-specific T-cell epitope in head and neck cancer patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Base

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198929

Lead and follow: the dance of the dendritic cell and T cell

15 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21970318

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Development of a new diagnostic tool for pancreatic cancer: simultaneous measurement of antibodies against peptides recognized by cytotoxic T lymphocytes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21970318

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21970318

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1479-5876-9-168

1 reference

Dimensions Publication ID

8 August 2017

0 references

1 reference

8 August 2017

1 reference